Sonoma Pharmaceuticals Inc. held its annual stockholders meeting on August 27, 2025. During the meeting, several proposals were presented and voted upon. Dr. Jay Birnbaum was elected as a Class II director. The advisory vote on executive compensation was approved. The appointment of Frazier & Deeter, LLC as the independent registered public accounting firm for the fiscal year ending March 31, 2026, was ratified. Additionally, a proposal to authorize the adjournment of the meeting to permit further solicitation of proxies, if necessary, was approved.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sonoma Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-25-006580), on August 29, 2025, and is solely responsible for the information contained therein.